How has been the historical performance of Metropolis Healt?
Metropolis Healt has shown consistent growth in net sales and profits from 761.18 Cr in Mar'19 to 1,331.20 Cr in Mar'25, with profit after tax increasing to 145.51 Cr in Mar'25. The company has effectively managed its liabilities while expanding its total assets significantly.
Answer:The historical performance of Metropolis Healt shows a consistent growth in net sales and profit over the years, with some fluctuations in profit margins. Breakdown:
Metropolis Healt's net sales have increased from 761.18 Cr in Mar'19 to 1,331.20 Cr in Mar'25, indicating a strong upward trend. Total operating income has followed a similar trajectory, reaching 1,331.20 Cr in Mar'25 from 761.18 Cr in Mar'19. The company's total expenditure, excluding depreciation, has also risen, from 560.81 Cr in Mar'19 to 1,028.21 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) has shown variability, peaking at 360.41 Cr in Mar'22 before settling at 318.10 Cr in Mar'25. Profit before tax reached 190.85 Cr in Mar'25, while profit after tax was 145.51 Cr, up from 128.46 Cr in Mar'24. The earnings per share (EPS) have increased to 27.99 in Mar'25 from 24.94 in Mar'24. The company's total assets have grown from 548.98 Cr in Mar'19 to 1,547.43 Cr in Mar'24, while total liabilities have decreased to 1,547.43 Cr in Mar'24 from 1,494.71 Cr in Mar'23. Cash flow from operating activities has improved, reaching 264.00 Cr in Mar'24, although the net cash outflow was -6.00 Cr in the same period. Overall, Metropolis Healt has demonstrated significant growth in sales and profits, alongside an increase in assets, while managing its liabilities effectively.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
